Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06971978 · ClinicalTrials.gov registry record · NA
Study to Assess the Effectiveness of a Heat Risk Reduction Decision Support Platform and the Barriers and Facilitators of Its Implementation With 30 US Local Health Department Sites
A NA study, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06971978: Active NA study, sponsored by University of Washington.
NCT06971978 is a NA study that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06971978, a NA study, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if an innovative online decision support tool (Chart) that provides localized health risk assessment for extreme heat at the census tract level helps local health departments plan and prepare for extreme heat by identifying risk drivers in their jurisdictions, highlighting interventions that are effective for their jurisdiction's risk profile, and providing information regarding intervention implementation. This trial will evaluate barriers and facilitators of the tool's implementation. The main questions it aims to answer are: 1. Does a health department using the tool have better reach, effectiveness, adoption, implementation, and maintenance of heat-health activities compared with an information-only control? 2. What are the barriers and facilitators of Chart's implementation? Researchers will compare health departments using Chart to health departments using provided heat-health information only.
Primary Outcome
All departments will undertake the pre-intervention baseline assessment. The baseline assessment will gather information related to organizational demographics and demographics of the communities that the organization serves.
Interventions
- OTHER Online decision support platform to support evidence-based heat health risk assessment and extreme heat event preparedness planning
- OTHER Heat and health risk assessment and preparedness information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What the registry record for NCT06971978 still lists
NCT06971978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Online decision support platform to support evidence-based heat health risk assessment and extreme heat event preparedness planning is the first listed.
NCT06971978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06971978 about?
NCT06971978 is a clinical study titled "Study to Assess the Effectiveness of a Heat Risk Reduction Decision Support Platform and the Barriers and Facilitators of Its Implementation With 30 US Local Health Department Sites". The goal of this clinical trial is to learn if an innovative online decision support tool (Chart) that provides localized health risk assessment for extreme heat at the census tract level helps local health departments plan and prepare for extreme heat by identifying risk drivers in their jurisdicti...
What is the current status of trial NCT06971978?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-01. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT06971978?
The interventions under investigation include: Online decision support platform to support evidence-based heat health risk assessment and extreme heat event preparedness planning (OTHER), Heat and health risk assessment and preparedness information (OTHER).
Who is sponsoring clinical trial NCT06971978?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06971978's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI